Daxor (DXR) News Today → Collapse of the Petrodollar (From Colonial Metals) (Ad) Free DXR Stock Alerts $8.67 -0.09 (-1.03%) (As of 06/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | finance.yahoo.comDaxor Corporation (DXR) Stock Price, News, Quote & History - Yahoo FinanceApril 16, 2024 | finance.yahoo.comNew Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionApril 15, 2024 | finance.yahoo.comDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)April 1, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the American College of Cardiology for ACC.24March 29, 2024 | investing.comDaxor CFO Michel Robert J buys $6.5k in company stockMarch 28, 2024 | money.usnews.comDestiny Tech100 IncMarch 28, 2024 | finance.yahoo.comDaxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | wsj.comDaxor Corp.March 22, 2024 | finance.yahoo.comDaxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024March 8, 2024 | finance.yahoo.comMulti-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure PatientsFebruary 12, 2024 | finance.yahoo.comDaxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer AcquisitionsFebruary 9, 2024 | benzinga.comDaxor Stock (NASDAQ:DXR) Insider TradesFebruary 7, 2024 | finance.yahoo.comDaxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing AccountsJanuary 29, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual MeetingJanuary 16, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care CongressJanuary 9, 2024 | finance.yahoo.comDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESJanuary 3, 2024 | msn.comDaxor seeks US FDA approval for blood volume analyserJanuary 2, 2024 | finance.yahoo.comDaxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume AnalyzerNovember 13, 2023 | seekingalpha.comAspira Women’s Health GAAP EPS of -$0.48 beats by $0.03, revenue of $2.22M misses by $0.68MNovember 13, 2023 | finanznachrichten.deDaxor Corporation: New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure PatientsNovember 13, 2023 | finance.yahoo.comNew Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure PatientsNovember 9, 2023 | finance.yahoo.comDaxor Corporation Awarded New Patent for Remote Monitoring of Blood VolumeNovember 7, 2023 | msn.comNeuronetics GAAP EPS of -$0.33 misses by $0.02, revenue of $17.9M beats by $0.32MNovember 5, 2023 | benzinga.comChief Financial Officer at Daxor Acquires Company Stock Options Worth 5,000 SharesOctober 13, 2023 | finance.yahoo.comExpert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific MeetingOctober 11, 2023 | finance.yahoo.comNew Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific MeetingOctober 4, 2023 | finance.yahoo.comDaxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services ProgramSeptember 27, 2023 | finance.yahoo.comDaxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023September 26, 2023 | finance.yahoo.comDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’23 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)September 13, 2023 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Daxor (DXR)September 11, 2023 | finance.yahoo.comDaxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis PatientsSeptember 7, 2023 | finance.yahoo.comDaxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 28, 2023 | marketwatch.comDaxor's Diagnostics Test Kits Revenue Climbs in 1HAugust 10, 2023 | finance.yahoo.comJACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®July 12, 2023 | finance.yahoo.comJACC-HF Study Compares Daxor’s BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure PatientsJuly 11, 2023 | finance.yahoo.comDaxor Corporation Announces Further Acquisitions and Increased Utilization of its BVA-100® Blood Volume Diagnostic Throughout the U.S.July 5, 2023 | finance.yahoo.comDaxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume AnalyzerJune 22, 2023 | finance.yahoo.comDaxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary OfferingJune 20, 2023 | finance.yahoo.comDaxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual MeetingJune 15, 2023 | finance.yahoo.comDaxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab ServicesJune 12, 2023 | finance.yahoo.comDaxor Corporation to Participate in the Maxim Group Virtual Healthcare ConferenceMay 25, 2023 | finance.yahoo.comDaxor Corporation Announces Closing of $4.0 Million Underwritten Public OfferingMay 22, 2023 | msn.comWhy Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketMay 22, 2023 | msn.comDaxor Nosedives on Stock OfferingMay 22, 2023 | seekingalpha.comDaxor shares tumble after pricing stock offering at discountMay 22, 2023 | finance.yahoo.comDaxor Corporation Announces Pricing of $4.0 Million Underwritten Public OfferingMay 22, 2023 | msn.comDaxor stock tumbles 22% premarket after announcing plans to issue stockMay 22, 2023 | marketwatch.comDaxor Shares Tumble Premarket on Plans for Public Offering >DXRMay 19, 2023 | finance.yahoo.comDaxor Corporation Announces Proposed Underwritten Public OfferingMay 18, 2023 | finance.yahoo.comNew Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. DXR Media Mentions By Week DXR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXR News Sentiment▼0.000.77▲Average Medical News Sentiment DXR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXR Articles This Week▼00▲DXR Articles Average Week Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ansell News Today Carl Zeiss Meditec News Today Coloplast A/S News Today ConvaTec Group News Today Fisher & Paykel Healthcare News Today Gerresheimer News Today InnerScope Hearing Technologies News Today Innovative Eyewear News Today Nanosonics News Today Olympus News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:DXR) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersThe Only Energy Play You Should Be Looking AtWealthpin ProBiden replacement revealed?Paradigm PressNext President (Not Trump. Not Biden.)The Freeport Society[Webinar] Understanding Covered CallsOICWhat’s Pelosi Buying Now?AltimetryAlex's "Next Magnificent Seven" StocksThe Oxford ClubWrite this ticker symbol down…StocksToTradeWho are Nvidia’s Silent Partners?Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.